🇺🇸 FDA
Patent

US 12296004

Recombinant virus with diminished latency and methods of using same

granted A61KA61K2039/5254A61K39/12

Quick answer

US patent 12296004 (Recombinant virus with diminished latency and methods of using same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/5254, A61K39/12, A61K39/245, A61K39/25